Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human/Mouse XIAP Antibody, R&D Systems™

Mouse Monoclonal Antibody has been used in 5 publications
Supplier: R&D Systems MAB822
This item is not returnable.
View return policy
Description
XIAP Monoclonal specifically detects XIAP in Human, Mouse samples. It is validated for Western Blot, Knockout Validated.Specifications
XIAP | |
Monoclonal | |
LYOPH | |
Western Blot 2 ug/mL, Knockout Validated | |
P98170 | |
XIAP | |
E. coli-derived recombinant human XIAP Met1-Ser497 Accession # P98170 | |
100 μg | |
Primary | |
Detects human and mouse XIAP in direct ELISAs and Western blots. In direct ELISAs, no cross-reactivity with recombinant human (rh) cIAP-1 or rhcIAP-2 is observed. | |
Human, Mouse | |
Purified |
Western Blot, KnockDown | |
117320 | |
Unconjugated | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
API3X-linked inhibitor of apoptosis protein, apoptosis inhibitor 3, baculoviral IAP repeat-containing 4, baculoviral IAP repeat-containing protein 4, BIRC4, BIRC4XLP2, E3 ubiquitin-protein ligase XIAP, EC 6.3.2.-, hIAP3, hIAP-3, hILP, IAP3, IAP-3, IAP-like protein, ILP, ILP1, Inhibitor of apoptosis protein 3, MIHA, X-linked IAP, X-linked inhibitor of apoptosis | |
Mouse | |
Protein A or G purified from hybridoma culture supernatant | |
RUO | |
331 | |
Reconstitute at 0.5 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
IgG2a |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction